sodium glucose co-transporter inhibitorsatherosclerotic cardiovascular diseaseDiabetes mellitusglucose lowering therapiesacute coronary syndrome (ACS)type 2 diabetes mellitus
…le more patients in the post-intervention group were prescribed sodium glucose co-transporter inhibitors (297/362 [82.0%] vs 359/711 [50.5%]. All-cause mortality (5.2 v…